Freeline Reports Updated Data From Phase 1/2 B-AMAZE Trial in Hemophilia B
Updated dose-ranging data demonstrate potential for full normalization of FIX activity Long-term follow up data show durable FIX activity out...
News
SpectrumX announces launch of new high capacity SpectriPOD disinfection tunnels at Joshua v Pulev world title fight
LONDON, Dec. 14, 2020 (GLOBE NEWSWIRE) -- SpectrumX Healthcare Limited is delighted to announce the successful launch of new biosecurity...
Relay Therapeutics Announces a Worldwide License and Collaboration Agreement with Genentech for RLY-1971
Collaboration brings together clinical stage SHP2 and KRAS G12C inhibitors Relay Therapeutics will receive $75 million upfront and is eligible...
HEXO Corp announces results of its annual and special meeting of shareholders
OTTAWA, Dec. 14, 2020 (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO” or the “Company”) (TSX: HEXO; NYSE:HEXO) is pleased to announce the results of...
Amarin Highlights Multiple VASCEPA® (Icosapent Ethyl)-Related Scientific Findings Presented at National Lipid Association (NLA) Scientific Sessions 2020, Including First COVID-19 Clinical Results
REDUCE-IT® EPA Encore Presentation reinforces Eicosapentaenoic Acid (EPA) levels from VASCEPA® (icosapent ethyl) strongly correlated to cardiovascular outcomes, more so...
Pfizer and BioNTech Provide Data from German Phase 1/2 Study Further Characterizing Immune Response Following Immunization with Lead COVID-19 Vaccine Candidate BNT162b2
Analysis of 37 participants immunized with BNT162b2 showed a broad immune response with SARS-CoV-2-specific neutralizing antibodies, TH1 type CD4+ T...
Avricore Health Successfully Intergrates ID Now™ Rapid PCR Test Device, Offering Real-Time Covid-19 Reporting Direct From Instrument for First Time.
Earlier this fall, the Company announced a joint working agreement to integrate a major manufacturer’s devices with its HealthTab™ data...
Smiths Medical Announces Launch of Portex® EchoGlo® Peripheral Nerve Block Portfolio
Inspired Engineering for Enhanced Visualization MINNEAPOLIS--(BUSINESS WIRE)--#ourpassionyourlife--Smiths Medical, a leading medical device manufacturer, is excited to announce the launch of...
Spectrum Pharmaceuticals Appoints Nora Brennan to Board of Directors
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI) a biopharmaceutical company focused on novel and targeted oncology therapies, today announced the appointment...
Avaya Earns Frost & Sullivan Award for Excellence in Healthcare Solutions
Competitive Strategy Leadership Award Recognizes Avaya’s Extensive Portfolio and Overall Ability to Improve Patient Care and Engagement RALEIGH-DURHAM, N.C.--(BUSINESS WIRE)--Avaya...
Axonics® Announces Appointment of David M. Demski to Board of Directors
IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (Nasdaq: AXNX), a medical technology company that has developed and is commercializing novel implantable...
GE Healthcare and St. Luke’s University Health Network Accelerate Breast Cancer Care with First One-Stop Clinic in the U.S.
St. Luke’s University Health Network in Pennsylvania to serve as national model for rapid diagnostic breast cancer centers One-stop breast...
Survey: COVID-19 Pandemic Influencing Consumer Healthcare Behavior
MOUNTAIN VIEW, Calif., Dec. 14, 2020 /PRNewswire/ -- COVID-19 pandemic putting a spotlight on consumers' healthcare behavior, according to a new...
Made in Italy startups at GITEX 2020 DUBAI
DUBAI, UAE, Dec. 14, 2020 /PRNewswire/ -- "After all these tough months, it was amazing to be part of GITEX and...
TCR² Announces RECIST Response in Ovarian Cancer from Ongoing Phase 1/2 Trial of TC-210 in Treatment Refractory Mesothelin-Expressing Solid Tumors
- TC-210 induced tumor regression in all of the first eight patients - Ovarian cancer patient achieved confirmed RECIST partial...
National Lipid Association Releases Official Scientific Statement on Coronary Artery Calcium Scoring for ASCVD Risk Reduction
JACKSONVILLE, Fla., Dec. 12, 2020 (GLOBE NEWSWIRE) -- The National Lipid Association (NLA) today announced the release of its official...
Amarin Reports Encouraging Efficacy and Safety Results from Pilot Study Treating COVID-19 Infected Outpatients with VASCEPA® (Icosapent Ethyl) in Late Breaker Presentation at National Lipid Association (NLA) Scientific Sessions 2020
VASCEPA COVID-19 CardioLink-9 Randomized Trial suggests improvement in patient-reported COVID-19 symptoms while achieving its primary endpoint by demonstrating a 25%...
Intellia Therapeutics Achieves Normal Human Alpha-1 Antitrypsin Protein Levels in Non-Human Primates Through Targeted Gene Insertion for the Treatment of AAT Deficiency
Demonstrates modularity of Intellia’s in vivo liver insertion technology to durably restore protein, compared to traditional gene therapy Single-course administration...
Kraig Biocraft Laboratories Secures Bridge Funding and Files to Become Fully Reporting Company
ANN ARBOR, Mich., Dec. 11, 2020 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), announced...
Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19
U.S. FDA authorizes COVID-19 mRNA vaccine for emergency use; companies are prepared to deliver first doses in the U.S. immediatelyPfizer...